253 related articles for article (PubMed ID: 7635848)
1. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
Zajecka JM; Jeffries H; Fawcett J
J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
3. Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
Fava M; McGrath PJ; Sheu WP;
J Clin Psychopharmacol; 2003 Aug; 23(4):365-9. PubMed ID: 12920412
[TBL] [Abstract][Full Text] [Related]
4. Obsessive compulsive disorder, depression, and fluoxetine.
Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine treatment of dysthymia in the elderly.
Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
[TBL] [Abstract][Full Text] [Related]
6. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
7. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
[TBL] [Abstract][Full Text] [Related]
11. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
12. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
13. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop SR; Dornseif BE; Wernicke JF; Potvin JH
Psychopharmacol Bull; 1990; 26(2):173-80. PubMed ID: 2236453
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant treatment of depression in HIV-seropositive women.
Ferrando SJ; Rabkin JG; de Moore GM; Rabkin R
J Clin Psychiatry; 1999 Nov; 60(11):741-6. PubMed ID: 10584761
[TBL] [Abstract][Full Text] [Related]
16. Pattern analysis of antidepressant response to fluoxetine.
Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine for treatment-resistant unipolar depression.
Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
[TBL] [Abstract][Full Text] [Related]
18. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
19. What constitutes an adequate antidepressant trial for fluoxetine?
Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.
Glezer A; Byatt N; Cook R; Rothschild AJ
J Affect Disord; 2009 Sep; 117(1-2):18-23. PubMed ID: 19103462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]